China gives conditional approval for CNBG's COVID-19 vaccine

China has given conditional approval for general public use to a COVID-19 vaccine developed by China National Biotec Group (CNBG), an official with China's National Medical Products Commission told a media briefing on Thursday.

The approval is the first for general public use among a handful of Chinese coronavirus vaccine candidates in various stages of development.

Also Read: WHO to sift Chinese samples, data in hunt for virus origins